# Larimar Therapeutics, Inc.: Form 8-K, filed Nov 7, 2018

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2018-11-07
- Accepted by EDGAR: Nov 7, 2018, 16:15 ET
- Period: 2018-11-07
- Accession: 0001193125-18-320926
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312518320926/d607779d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312518320926/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312518320926/d607779d8k.htm

Filed Nov 7, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-320926. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
